Innovation Pharmaceuticals Inc (IPIX)

[djs7]

The ? may be when the end of Phase 2 meeting took place for Brilacidin-OM. My guess would be the end of Phase 2 meeting occurred after the July 17 PR announcing the CoreRx sachet agreement for Brilacidin-OM.

http://www.ipharminc.com/press-release/2018/7/17/innovation-pharmaceuticals-signs-drug-product-manufacturing-contract-with-corerx-to-formulate-and-package-brilacidin-for-oral-mucositis-in-sachet-form

A Breakthrough Therapy Designation request is due to the FDA by the time an end of Phase 2 meeting begins.